Suggestions
Minnie Sarwal
Professor, UCSF, Stanford; Founder, Nephrosant, Inc.
Dr. Minnie Sarwal is a prominent nephrologist, researcher, and professor at the University of California, San Francisco (UCSF). Here are some key details about her background and accomplishments:
Education and Training
Dr. Sarwal received her medical degree from Calcutta National Medical College in India.1 She went on to obtain additional qualifications in the UK, including:
- Diploma in Child Health (DCH) from London University
- Membership of the Royal College of Physicians (MRCP) in 1990
- PhD in Molecular Genetics from Cambridge University in 19952
Current Position
She currently serves as:
- Professor in Residence of Surgery at UCSF
- Director of the Precision Transplant Medicine Initiative at UCSF24
Areas of Expertise
Dr. Sarwal specializes in:
- Adult and pediatric nephrology
- Transplant immunology
- Kidney and pancreas transplantation
- Acute and chronic renal failure
- Glomerular disease12
Research and Innovations
She has made significant contributions to the field of organ transplantation, including:
- Conducting the first successful complete steroid avoidance trial in the US for kidney transplants
- Pioneering genomic and proteomic investigations into organ transplant injury mechanisms
- Developing blood tests for early diagnosis of kidney transplant rejection2
Entrepreneurship
Dr. Sarwal has founded multiple biotechnology companies:
- Organ-i in 2009 (acquired by Immucor in 2014)
- NephroSant, where she serves as Chief Medical Officer23
Academic Achievements
- Author of over 290 scientific publications
- Inventor on over 20 patents
- Editor of handbooks and journals in nephrology and transplantation2
Awards and Recognition
- Cuneo Richardson Award for outstanding contributions to kidney disease research
- TTS-Roche award for excellence in clinical translational science in organ transplantation2
Dr. Sarwal's work spans clinical care, research, and innovation in nephrology and transplantation, making her a leading figure in the field.
Highlights
Jan 3 · PRNewswire
NephroSant Features QSant, the first urine test for kidney transplant rejection, at Biotech Showcase Digital 2022 - PRNewswire
Jan 3 · Yahoo Finance
NephroSant Features QSant, the first urine test for kidney transplant rejection, at Biotech Showcase Digital 2022 - Yahoo Finance
Get intro to Minnie
Add to my network
Location
San Francisco Bay Area
People also viewed
Leah Houston, MD
Founder at evercred we automate physician workforce mobility for optimized patient access to care
Russ Cucina
Vice President, Genetics and Genomics & Chief Medical Information Officer at the University of California, San Francisco Health System
Amit Mehta MD, MBA
CEO ABM Pain Consultants LLC, CMO Pain Management Doctorpedia, Physician/Advisor ClaimsEval,
Interventional Pain Specialist/Anesthesiologist/Consultant/Entrepreneur
Mutual Connections
See who you know in common with Minnie
Clay can make mistakes, so please verify responses. Data is from public sources. Trademarks are property of their respective owners.
People also viewed
Leah Houston, MD
Founder at evercred we automate physician workforce mobility for optimized patient access to care
Russ Cucina
Vice President, Genetics and Genomics & Chief Medical Information Officer at the University of California, San Francisco Health System
Amit Mehta MD, MBA
CEO ABM Pain Consultants LLC, CMO Pain Management Doctorpedia, Physician/Advisor ClaimsEval,
Interventional Pain Specialist/Anesthesiologist/Consultant/Entrepreneur
Mutual Connections
See who you know in common with Minnie